This protection against MetS risk could be due to the increase in the response to the action of leptin and insulin and the reduction in the signaling of IL-6 and other inflammatory cytokines, which have been proven in the laboratory setting with animal subjects undergoing SOC3 methylation or neuron-specific SOC3 knockout (Babon et al., 2012). Here, INS is linked to metabolic syndrome.